Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cardiovascular Intervention and Therapeutics
Published in: Cardiovascular Intervention and Therapeutics 2/2011

01-05-2011 | Case Report

Remote infarction following percutaneous transluminal septal myocardial ablation: a report of two cases

Authors: Nagamani Alur Chikkabasavaiah, Beeresha Puttegowda, Arunkumar Panneerselvam, Rajiv Ananthakrishna, Aravinda Prasad Kapanigowda, Ramesh Basavappa

Published in: Cardiovascular Intervention and Therapeutics | Issue 2/2011

Login to get access

Abstract

Percutaneous transluminal septal myocardial ablation is an established therapeutic option for symptomatic hypertrophic obstructive cardiomyopathy refractory to medical therapy. It is a safe procedure in experienced hands, but complications can occur. We report two cases of right ventricular myocardial infarction with inferior wall infarction that occurred after alcohol ablation of the septum. There are no standard guidelines regarding the most appropriate treatment strategy in this clinical scenario. The probable mechanism and management issues are discussed.
Literature
1.
van der Lee C, ten Cate FJ, Geleijnse ML, Kofflard MJ, Pedone C, van Herwerden LA, Biagini E, Vletter WB, Serruys PW. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets Circulation. 2005;26, 112(4):482–8.
2.
Maron BJ, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003;42(9):1687–713.PubMedCrossRef
3.
Agarwal SC, Purcell IF, Furniss SS. Apical myocardial injury caused by collateralisation of a septal artery during ethanol septal ablation. Heart. 2005;91(1):e2.PubMedCrossRef
4.
Parham WA, Kern MJ. Apical infarct via septal collateralization complicating transluminal alcohol septal ablation for hypertrophic cardiomyopathy. Catheter Cardiovasc Interv. 2003;60(2):208–11.PubMedCrossRef
5.
Li ZQ, Cheng TO, Zhang WW, Qiao SB, Zhao LY, Jin YZ, Guan RM, Liu L. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy; the Chinese experience in 119 patients from a single center. Int J Cardiol. 2004;93(2–3):197–202.PubMedCrossRef
6.
Chowdhary S, Galiwango P, Woo A, Schwartz L. Inferior infarction following alcohol septal ablation: a consequence of “collateral damage”? Catheter Cardiovasc Interv. 2007;1, 69(2):236–42.
7.
Wustmann K, Zbinden S, Windecker S, Meier B, Seiler C. Is there functional collateral flow during vascular occlusion in angiographically normal coronary arteries? Circulation. 2003;6, 107(17):2213–20.
8.
Durand E, Mousseaux E, Coste P, Pillière R, Dubourg O, Trinquart L, Chatellier G, Hagège A, Desnos M, Lafont A. Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up. Eur Heart J. 2008;29(3):348–55.PubMedCrossRef
Metadata
Title
Remote infarction following percutaneous transluminal septal myocardial ablation: a report of two cases
Authors
Nagamani Alur Chikkabasavaiah
Beeresha Puttegowda
Arunkumar Panneerselvam
Rajiv Ananthakrishna
Aravinda Prasad Kapanigowda
Ramesh Basavappa
Publication date
01-05-2011
Publisher
Springer Japan
Published in
Cardiovascular Intervention and Therapeutics / Issue 2/2011
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-010-0038-8

Other articles of this Issue 2/2011

Cardiovascular Intervention and Therapeutics 2/2011 Go to the issue

Original Article

Which DES is the most appropriate for very small target vessels? Experimental study of stent expandable performance with SES, PES, ZES and EES

Review Article

Coronary angioscopy: current topics and future direction

Case Report

Intraoperative pulmonary artery stenting in aortoarteritis: a hybrid procedure

Case Report

The potential of surgical strategy for incomplete stent apposition after implantation of a sirolimus eluting stent

Case Report

Diagnosing dialysis access steal syndrome using skin perfusion pressure with an occlusion balloon

Case Report

Novel transcatheter closure of internal iliac arteriovenous malformation

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits